{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:00:38Z","timestamp":1792512038645,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40264-025-01526-9","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:43:58Z","timestamp":1742035438000},"page":"739-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZ"],"prefix":"10.1007","volume":"48","author":[{"given":"Mona","family":"Gerentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Lajnef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Sz\u00f6ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Aouizerate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Cl\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ch\u00e9reau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Clauss-Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Dorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Fond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lia","family":"Godin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudi","family":"Goze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Leignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Michel","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Oriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"V\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FACE-SZ (FondaMental Academic Centers of Expertise-Schizophrenia) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Andrieu-Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Aouizerate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Capdevielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cl\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Chereau-Boudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Clauss-Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dassing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Dorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Esselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Fond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Gabayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jarroir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lacelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Leignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Metairie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Passerieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Portalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sz\u00f6ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zinetti-Bertschy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0526-3136","authenticated-orcid":false,"given":"Baptiste","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"1526_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","volume":"170","author":"C Crump","year":"2013","unstructured":"Crump C, Winkleby MA, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. AJP. 2013;170:324\u201333.","journal-title":"AJP."},{"key":"1526_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1192\/bjp.bp.117.202606","volume":"211","author":"JF Hayes","year":"2017","unstructured":"Hayes JF, Marston L, Walters K, King MB, Osborn DPJ. Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000\u20132014. Br J Psychiatry. 2017;211:175\u201381.","journal-title":"Br J Psychiatry"},{"key":"1526_CR3","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jpsychires.2013.07.011","volume":"47","author":"Z Fan","year":"2013","unstructured":"Fan Z, Wu Y, Shen J, Ji T, Zhan R. Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies. J Psychiatr Res. 2013;47:1549\u201356.","journal-title":"J Psychiatr Res"},{"key":"1526_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/PSY.0000000000000863","volume":"82","author":"C Kowal","year":"2020","unstructured":"Kowal C, Peyre H, Amad A, Pelissolo A, Leboyer M, Sch\u00fcrhoff F, et al. Psychotic, mood, and anxiety disorders and venous thromboembolism: a systematic review and meta-analysis. Psychosom Med. 2020;82:838\u201349.","journal-title":"Psychosom Med"},{"key":"1526_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/schbul\/sbab132","volume":"48","author":"RR Veeneman","year":"2022","unstructured":"Veeneman RR, Vermeulen JM, Abdellaoui A, Sanderson E, Wootton RE, Tadros R, et al. Exploring the relationship between schizophrenia and cardiovascular disease: a genetic correlation and multivariable mendelian randomization study. Schizophr Bull. 2022;48:463\u201373.","journal-title":"Schizophr Bull"},{"key":"1526_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/acps.13017","volume":"139","author":"IH Heiberg","year":"2019","unstructured":"Heiberg IH, Jacobsen BK, Balteskard L, Bramness JG, N\u00e6ss \u00d8, Ystrom E, et al. Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness. Acta Psychiatr Scand. 2019;139:558\u201371.","journal-title":"Acta Psychiatr Scand"},{"key":"1526_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11920-024-01500-9","volume":"26","author":"A Sz\u00f6ke","year":"2024","unstructured":"Sz\u00f6ke A, Pignon B, Godin O, Ferchiou A, Tamouza R, Leboyer M, et al. Multimorbidity and the etiology of schizophrenia. Curr Psychiatry Rep. 2024;26:253\u201363.","journal-title":"Curr Psychiatry Rep"},{"key":"1526_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1177\/0269881117714047","volume":"31","author":"K-L Huang","year":"2017","unstructured":"Huang K-L, Fang C-J, Hsu C-C, Wu S-I, Juang JJ, Stewart R. Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies. J Psychopharmacol. 2017;31:1544\u201355.","journal-title":"J Psychopharmacol"},{"key":"1526_CR9","doi-asserted-by":"crossref","unstructured":"Ferraris A, Szmulewicz AG, Posadas-Mart\u00ednez ML, Serena MA, Vazquez FJ, Angriman F. The effect of antipsychotic treatment on recurrent venous thromboembolic disease: a cohort study. J Clin Psychiatry. 2019;80(5):18m12656.","DOI":"10.4088\/JCP.18m12656"},{"key":"1526_CR10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","volume":"47","author":"N Stogios","year":"2022","unstructured":"Stogios N, Smith E, Bowden S, Tran V, Asgariroozbehani R, McIntyre WB, et al. Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Neuropsychopharmacol. 2022;47:664\u201372.","journal-title":"Neuropsychopharmacol"},{"key":"1526_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","volume":"40","author":"L Hirsch","year":"2017","unstructured":"Hirsch L, Yang J, Bresee L, Jette N, Patten S, Pringsheim T. Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies. Drug Saf. 2017;40:771\u201381.","journal-title":"Drug Saf"},{"key":"1526_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11892-019-1220-8","volume":"19","author":"RIG Holt","year":"2019","unstructured":"Holt RIG. Association between antipsychotic medication use and diabetes. Curr Diab Rep. 2019;19:96.","journal-title":"Curr Diab Rep"},{"key":"1526_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40263-014-0196-9","volume":"28","author":"M Hasnain","year":"2014","unstructured":"Hasnain M, Vieweg WVR. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs. 2014;28:887\u2013920.","journal-title":"CNS Drugs"},{"key":"1526_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/hup.2540","volume":"31","author":"G Carr\u00e0","year":"2016","unstructured":"Carr\u00e0 G, Crocamo C, Bartoli F, Lax A, Tremolada M, Lucii C, et al. First-generation antipsychotics and QTc: any role for mediating variables? Hum Psychopharmacol Clin Exp. 2016;31:313\u20138.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"1526_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-022-06293-4","volume":"240","author":"C Bordet","year":"2023","unstructured":"Bordet C, Garcia P, Salvo F, Touafchia A, Galinier M, Sommet A, et al. Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Psychopharmacology. 2023;240:199\u2013202.","journal-title":"Psychopharmacology"},{"key":"1526_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/pace.13296","volume":"41","author":"N El-Sherif","year":"2018","unstructured":"El-Sherif N, Turitto G, Boutjdir M. Acquired long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol. 2018;41:414\u201321.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1526_CR17","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1161\/CIRCULATIONAHA.108.191096","volume":"119","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju PM, Surawicz B, Gettes LS. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram. Circulation. 2009;119:e241\u201350.","journal-title":"Circulation"},{"key":"1526_CR18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","volume":"67","author":"PJ Schwartz","year":"2016","unstructured":"Schwartz PJ, Woosley RL. Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol. 2016;67:1639\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"1526_CR19","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2024.25","volume":"67","author":"S Li","year":"2024","unstructured":"Li S, Xu C, Hu S, Lai J. Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis. Eur Psychiatry. 2024;67: e29.","journal-title":"Eur Psychiatry"},{"key":"1526_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1176\/appi.ajp.20230025","volume":"180","author":"MK Jha","year":"2023","unstructured":"Jha MK, Mathew SJ. Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry. 2023;180:190\u20139.","journal-title":"Am J Psychiatry"},{"key":"1526_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/ijnp\/pyac050","volume":"25","author":"A Tajika","year":"2022","unstructured":"Tajika A, Hori H, Iga J, Koshikawa Y, Ogata H, Ogawa Y, et al. Mood stabilizers and antipsychotics for acute mania: systematic review and meta-analysis of augmentation therapy vs monotherapy from the perspective of time to the onset of treatment effects. Int J Neuropsychopharmacol. 2022;25:839\u201352.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1526_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","volume":"355","author":"JG Reilly","year":"2000","unstructured":"Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355:1048\u201352.","journal-title":"Lancet"},{"key":"1526_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1034\/j.1600-0447.2003.02078.x","volume":"107","author":"DM Taylor","year":"2003","unstructured":"Taylor DM. Antipsychotics and QT prolongation. Acta Psychiatr Scand. 2003;107:85\u201395.","journal-title":"Acta Psychiatr Scand"},{"key":"1526_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","volume":"24","author":"EP Harrigan","year":"2004","unstructured":"Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004;24:62\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"1526_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, \u00d6rey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951\u201362.","journal-title":"Lancet"},{"key":"1526_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939\u201351.","journal-title":"Lancet"},{"key":"1526_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/pds.1607","volume":"17","author":"C \u00c5str\u00f6m-Lilja","year":"2008","unstructured":"\u00c5str\u00f6m-Lilja C, Odeberg JM, Ekman E, H\u00e4gg S. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2008;17:587\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1526_CR28","doi-asserted-by":"publisher","first-page":"E609","DOI":"10.1208\/aapsj070363","volume":"7","author":"V Piotrovsky","year":"2005","unstructured":"Piotrovsky V. Pharmacokinetic\u2013pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT\/QTc prolongation. AAPS J. 2005;7:E609-624.","journal-title":"AAPS J"},{"key":"1526_CR29","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","volume":"121","author":"BJ Drew","year":"2010","unstructured":"Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121:1047\u201360.","journal-title":"Circulation"},{"key":"1526_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.eurpsy.2015.05.004","volume":"30","author":"F Sch\u00fcrhoff","year":"2015","unstructured":"Sch\u00fcrhoff F, Fond G, Berna F, Bulzacka E, Vilain J, Capdevielle D, et al. A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur Psychiatry. 2015;30:728\u201335.","journal-title":"Eur Psychiatry"},{"key":"1526_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2019.04.006","volume":"208","author":"B Pignon","year":"2019","unstructured":"Pignon B, Lajnef M, Godin O, Geoffray M-M, Rey R, Mallet J, et al. Relationship between childhood trauma and level of insight in schizophrenia: a path-analysis in the national FACE-SZ dataset. Schizophr Res. 2019;208:90\u20136.","journal-title":"Schizophr Res"},{"key":"1526_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109927","volume":"101","author":"G Fond","year":"2020","unstructured":"Fond G, Godin O, Sch\u00fcrhoff F, Berna F, Andr\u00e9 M, Aouizerate B, et al. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort. Prog Neuropsychopharmacol Biol Psychiatry. 2020;101: 109927.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1526_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jpsychires.2023.03.017","volume":"161","author":"A Sz\u00f6ke","year":"2023","unstructured":"Sz\u00f6ke A, Richard J-R, Fond G, Misdrahi D, Lajnef M, Aouizerate B, et al. Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia\u2014data from the FACE-SZ cohort. J Psychiatr Res. 2023;161:206\u201312.","journal-title":"J Psychiatr Res"},{"key":"1526_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12804","volume":"26","author":"P Dahlberg","year":"2021","unstructured":"Dahlberg P, Diamant U-B, Gilljam T, Rydberg A, Bergfeldt L. QT correction using Bazett\u2019s formula remains preferable in long QT syndrome type 1 and 2. Ann Noninvasive Electrocardiol. 2021;26: e12804.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"1526_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2165\/00003495-199448020-00009","volume":"48","author":"S Grant","year":"1994","unstructured":"Grant S, Fitton A. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs. 1994;48:253\u201373.","journal-title":"Drugs"},{"key":"1526_CR36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00228-017-2406-0","volume":"74","author":"F Montastruc","year":"2018","unstructured":"Montastruc F, B\u00e9nard-Laribi\u00e8re A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, et al. Antipsychotics use: 2006\u20132013 trends in prevalence and incidence and characterization of users. Eur J Clin Pharmacol. 2018;74:619\u201326.","journal-title":"Eur J Clin Pharmacol"},{"key":"1526_CR37","unstructured":"AZCERT. For Healthcare Providers: Crediblemeds [Internet]. 2023 [cited 2023 Aug 1]. https:\/\/crediblemeds.org\/healthcare-providers."},{"key":"1526_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.schres.2007.12.470","volume":"100","author":"MJ Byerly","year":"2008","unstructured":"Byerly MJ, Nakonezny PA, Rush AJ. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res. 2008;100:60\u20139.","journal-title":"Schizophr Res"},{"key":"1526_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41398-023-02640-x","volume":"13","author":"D Misdrahi","year":"2023","unstructured":"Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, et al. Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset. Transl Psychiatry. 2023;13:341.","journal-title":"Transl Psychiatry"},{"key":"1526_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1192\/pb.21.4.224","volume":"21","author":"M Atkins","year":"1997","unstructured":"Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull. 1997;21:224\u20136.","journal-title":"Psychiatr Bull"},{"key":"1526_CR41","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686\u201393.","journal-title":"Am J Psychiatry"},{"key":"1526_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00004850-198904000-00001","volume":"4","author":"MJ Rey","year":"1989","unstructured":"Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol. 1989;4:95\u2013104.","journal-title":"Int Clin Psychopharmacol"},{"key":"1526_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148212","volume":"11","author":"C Barbui","year":"2016","unstructured":"Barbui C, Bighelli I, Carr\u00e0 G, Castellazzi M, Lucii C, Martinotti G, et al. Antipsychotic dose mediates the association between polypharmacy and corrected QT interval. PLoS ONE. 2016;11: e0148212.","journal-title":"PLoS ONE"},{"key":"1526_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1517\/14656566.3.5.479","volume":"3","author":"PJ Goodnick","year":"2002","unstructured":"Goodnick PJ, Jerry J, Parra F. Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother. 2002;3:479\u201398.","journal-title":"Expert Opin Pharmacother"},{"key":"1526_CR45","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1007\/s00213-015-4024-9","volume":"232","author":"C Polcwiartek","year":"2015","unstructured":"Polcwiartek C, Sneider B, Graff C, Taylor D, Meyer J, Kanters JK, et al. The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach. Psychopharmacology. 2015;232:3297\u2013308.","journal-title":"Psychopharmacology"},{"key":"1526_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100069","volume":"9","author":"RC Kling","year":"2014","unstructured":"Kling RC, Tschammer N, Lanig H, Clark T, Gmeiner P. Active-state model of a dopamine D2 receptor\u2014G\u03b1i complex stabilized by aripiprazole-type partial agonists. PLoS ONE. 2014;9: e100069.","journal-title":"PLoS ONE"},{"key":"1526_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4088\/JCP.v61n0609","volume":"61","author":"UG Kang","year":"2000","unstructured":"Kang UG, Kwon JS, Ahn YM, Chung SJ, Ha JH, Koo YJ, et al. Electrocardiographic abnormalities in patients treated with clozapine. J Clin Psychiatry. 2000;61:441\u20136.","journal-title":"J Clin Psychiatry"},{"key":"1526_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/01.jcp.0000150217.51433.9f","volume":"25","author":"DB Merrill","year":"2005","unstructured":"Merrill DB, Dec GW, Goff DC. Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol. 2005;25:32\u201341.","journal-title":"J Clin Psychopharmacol"},{"key":"1526_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2017.12.102","volume":"259","author":"BL Bellissima","year":"2018","unstructured":"Bellissima BL, Tingle MD, Cicovi\u0107 A, Alawami M, Kenedi C. A systematic review of clozapine-induced myocarditis. Int J Cardiol. 2018;259:122\u20139.","journal-title":"Int J Cardiol"},{"key":"1526_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00004714-200102000-00003","volume":"21","author":"MW Agelink","year":"2001","unstructured":"Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol. 2001;21:8\u201313.","journal-title":"J Clin Psychopharmacol"},{"key":"1526_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1192\/bjp.179.2.167","volume":"179","author":"H Cohen","year":"2001","unstructured":"Cohen H, Loewenthal U, Matar M, Kotler M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry. 2001;179:167\u201371.","journal-title":"Br J Psychiatry"},{"key":"1526_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.schres.2023.09.032","volume":"268","author":"A Sankaranarayanan","year":"2024","unstructured":"Sankaranarayanan A, Kazi S, Andrade C. Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia. Schizophr Res. 2024;268:145\u20139.","journal-title":"Schizophr Res"},{"key":"1526_CR53","volume-title":"Psychopharmacologie Essentielle","author":"SM Stahl","year":"2015","unstructured":"Stahl SM. Psychopharmacologie Essentielle. 4th ed. Paris: Librairie Lavoisier; 2015.","edition":"4"},{"key":"1526_CR54","first-page":"1","volume":"Suppl 10","author":"CE Leonard","year":"2013","unstructured":"Leonard CE, Freeman CP, Newcomb CW, Bilker WB, Kimmel SE, Strom BL, et al. Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in medicaid and dually-eligible medicaid-medicare beneficiaries of five states. J Clin Exp Cardiolog. 2013;Suppl 10:1\u20139.","journal-title":"J Clin Exp Cardiolog."},{"key":"1526_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","volume":"54","author":"SR Beach","year":"2013","unstructured":"Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54:1\u201313.","journal-title":"Psychosomatics"},{"key":"1526_CR56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.15420\/aer.2018.29.2","volume":"7","author":"S Sicouri","year":"2018","unstructured":"Sicouri S, Antzelevitch C. Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest. Arrhythm Electrophysiol Rev. 2018;7:199\u2013209.","journal-title":"Arrhythm Electrophysiol Rev."},{"key":"1526_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","volume":"12","author":"LX Cubeddu","year":"2016","unstructured":"Cubeddu LX. Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias. Curr Cardiol Rev. 2016;12:141\u201354.","journal-title":"Curr Cardiol Rev"},{"key":"1526_CR58","first-page":"690","volume":"8","author":"PM Rautaharju","year":"1992","unstructured":"Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992;8:690\u20135.","journal-title":"Can J Cardiol"},{"key":"1526_CR59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/070674371506000502","volume":"60","author":"SW Rabkin","year":"2015","unstructured":"Rabkin SW. Impact of age and sex on QT prolongation in patients receiving psychotropics. Can J Psychiatry. 2015;60:206\u201314.","journal-title":"Can J Psychiatry"},{"key":"1526_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijcard.2005.01.041","volume":"106","author":"M Facchini","year":"2006","unstructured":"Facchini M, Sala L, Malfatto G, Bragato R, Redaelli G, Invitti C. Low-K+ dependent QT prolongation and risk for ventricular arrhythmia in anorexia nervosa. Int J Cardiol. 2006;106:170\u20136.","journal-title":"Int J Cardiol"},{"key":"1526_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","volume":"39","author":"E Vandael","year":"2017","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39:16\u201325.","journal-title":"Int J Clin Pharm"},{"key":"1526_CR62","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.psychres.2008.06.031","volume":"169","author":"B Trojak","year":"2009","unstructured":"Trojak B, Astruc K, Pinoit J-M, Chauvet-Gelinier J-C, Ponavoy E, Bonin B, et al. Hypokalemia is associated with lengthening of QT interval in psychiatric patients on admission. Psychiatry Res. 2009;169:257\u201360.","journal-title":"Psychiatry Res"},{"key":"1526_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-1781(99)00018-9","volume":"86","author":"K Hatta","year":"1999","unstructured":"Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Yonezawa Y. Hypokalemia and agitation in acute psychotic patients. Psychiatry Res. 1999;86:85\u20138.","journal-title":"Psychiatry Res"},{"key":"1526_CR64","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.orcp.2016.09.005","volume":"11","author":"S Waheed","year":"2017","unstructured":"Waheed S, Dawn B, Gupta K. Association of corrected QT interval with body mass index, and the impact of this association on mortality: results from the Third National Health and Nutrition Examination Survey. Obes Res Clin Pract. 2017;11:426\u201334.","journal-title":"Obes Res Clin Pract"},{"key":"1526_CR65","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fphys.2017.00431","volume":"8","author":"AS Aromolaran","year":"2017","unstructured":"Aromolaran AS, Boutjdir M. Cardiac ion channel regulation in obesity and the metabolic syndrome: relevance to long QT syndrome and atrial fibrillation. Front Physiol. 2017;8:431.","journal-title":"Front Physiol"},{"key":"1526_CR66","doi-asserted-by":"crossref","unstructured":"Godin O, Bennabi D, Yrondi A, Richieri R, D\u2019Amato T, Bellivier F, et al. Prevalence of metabolic syndrome and associated factors in a cohort of individuals with treatment-resistant depression: results from the FACE-DR study. J Clin Psychiatry. 2019;80:19m12755.","DOI":"10.4088\/JCP.19m12755"},{"key":"1526_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110641","volume":"120","author":"O Godin","year":"2023","unstructured":"Godin O, Pignon B, Szoke A, Boyer L, Aouizerate B, Schorr B, et al. 3-Year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort. Prog Neuropsychopharmacol Biol Psychiatry. 2023;120: 110641.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1526_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.schres.2009.09.041","volume":"116","author":"R Ramos-R\u00edos","year":"2010","unstructured":"Ramos-R\u00edos R, Arrojo-Romero M, Paz-Silva E, Carballal-Calvo F, Bouz\u00f3n-Barreiro JL, Seoane-Prado J, et al. QTc interval in a sample of long-term schizophrenia inpatients. Schizophr Res. 2010;116:35\u201343.","journal-title":"Schizophr Res"},{"key":"1526_CR69","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1176\/appi.ajp.2013.12060860","volume":"170","author":"FR Girardin","year":"2013","unstructured":"Girardin FR, Gex-Fabry M, Berney P, Shah D, Gaspoz J-M, Dayer P. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study. Am J Psychiatry. 2013;170:1468\u201376.","journal-title":"Am J Psychiatry"},{"key":"1526_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-2006-924083","volume":"114","author":"D Ziegler","year":"2006","unstructured":"Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006;114:153\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1526_CR71","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jelectrocard.2020.01.003","volume":"59","author":"L \u00d6zdemir","year":"2020","unstructured":"\u00d6zdemir L, S\u00f6kmen E. Effect of habitual cigarette smoking on the index of cardiac electrophysiological balance in apparently healthy individuals. J Electrocardiol. 2020;59:41\u20134.","journal-title":"J Electrocardiol"},{"key":"1526_CR72","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/hup.2515","volume":"31","author":"M Okubo","year":"2016","unstructured":"Okubo M, Narita M, Murayama N, Akimoto Y, Goto A, Yamazaki H. Individual differences in in vitro and in vivo metabolic clearances of the antipsychotic drug olanzapine from non-smoking and smoking Japanese subjects genotyped for cytochrome P4502D6 and flavincontaining monooxygenase 3. Hum Psychopharmacol Clin Exp. 2016;31:83\u201392.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"1526_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004216","volume":"4","author":"Y Tsuda","year":"2014","unstructured":"Tsuda Y, Saruwatari J, Yasui-Furukori N. Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine. BMJ Open. 2014;4: e004216.","journal-title":"BMJ Open"},{"key":"1526_CR74","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0091270006286900","volume":"46","author":"B Darpo","year":"2006","unstructured":"Darpo B, Agin M, Kazierad DJ, Layton G, Muirhead G, Gray P, et al. Man versus machine: is there an optimal method for QT measurements in thorough QT studies? J Clin Pharmacol. 2006;46:598\u2013612.","journal-title":"J Clin Pharmacol"},{"key":"1526_CR75","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jelectrocard.2006.09.003","volume":"40","author":"JW Mason","year":"2007","unstructured":"Mason JW, Ramseth DJ, Chanter DO, Moon TE, Goodman DB, Mendzelevski B. Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. J Electrocardiol. 2007;40:228\u201334.","journal-title":"J Electrocardiol"},{"key":"1526_CR76","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/hrt.77.6.539","volume":"77","author":"A Murray","year":"1997","unstructured":"Murray A, McLaughlin NB, Campbell RW. Measuring QT dispersion: man versus machine. Heart. 1997;77:539\u201342.","journal-title":"Heart"},{"key":"1526_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/157488610789869265","volume":"5","author":"PA Alvarez","year":"2010","unstructured":"Alvarez PA, Pahissa J. QT alterations in psychopharmacology: proven candidates and suspects. Curr Drug Saf. 2010;5:97\u2013104.","journal-title":"Curr Drug Saf"},{"key":"1526_CR78","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.encep.2007.06.009","volume":"34","author":"V Frimas","year":"2008","unstructured":"Frimas V, Roberge C, Perroux D, Dauvillier J-M. Cardiological monitoring of antipsychotic-treated patients: evaluation and evolution of a hospital protocol. Encephale. 2008;34:467\u201376.","journal-title":"Encephale."},{"key":"1526_CR79","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.lpm.2018.03.001","volume":"47","author":"C Tezenas du Montcel","year":"2018","unstructured":"Tezenas du Montcel C, Kowal C, Leherle A, Kabbaj S, Frajerman A, Le Guen E, et al. Isolement et contention m\u00e9canique dans les soins psychiatriques: modalit\u00e9s de prescription, prise en charge et surveillance. La Presse M\u00e9dicale. 2018;47:349\u201362.","journal-title":"La Presse M\u00e9dicale"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01526-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:02:08Z","timestamp":1750154528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01526-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01526-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"9 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the \u201cInvestissements d'Avenir\u201d programmes managed by the ANR under references ANR-11-IDEX-0004-02 and ANR-10-COHO-10-01. The funding source had no further involvement in study design; the collection, analysis and interpretation of data; the writing of the report or in the decision to submit the article for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The Authors have declared that there are no conflicts of interest in relation to the subject of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Data are not available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The code is not available.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"MG, MoLa, FS and BP devised the study design. Data collection was conducted by the FACE-SZ collaborators. MG and MoLa conducted data analysis, had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. MG and BP wrote the first draft of the manuscript. MG, AS, BA, FB, MC, IS, NC, JCK, EF, JMD, CD, GF, OG, TG, CL, MaLe, SL, PML, JM, DM, NO, RR, PR, BS, MU, EV, FS and BP participated in interpreting the results, manuscript editing and figure revision. All authors approved the final version of the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The assessment protocol was approved by the ethics review board (CPP-Ile de France IX, January 18, 2010), which required providing all patients with an informational letter but waived the requirement for written informed consent.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study was conducted using data collected from Expert Centres as part of regular care evaluations. The research is classified as observational and non-interventional. It received a favourable opinion from the French Advisory Committee on Information Processing for Health Research (CCTIRS) and authorization from the French National Commission on Informatics and Liberty (CNIL). Patients were informed through an information letter, and a non-opposition form was provided to them for the collection and use of their data for research purposes.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients were informed through an information letter, and a non-opposition form was provided for the collection and use of their data for research purposes.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}